5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases

Ting Lan; Yongzhen Zou; Michael R Hamblin; Rui Yin

doi:10.1016/j.pdpdt.2017.12.003

Back

5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy

Connor Thunshelle, Rui Yin, Qiquan Chen, Michael R Hamblin

Article2010

Differential hypermethylation of genes in vulvar cancer and lichen sclerosus coexisting or not with vulvar cancer

David Guerrero, Rosa Guarch, Amaya Ojer, Juan Manuel Casas Fernández de Tejerina, Carolina Méndez‐Meca, Manel Esteller, Edurne Barba‐Ramos, F. García-Bragado, A Puras

Article2002

Alterations of the p16INK4a/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus

Enrique Lerma, Manel Esteller, James G. Herman, Jaime Prat

Article2018

Remodeling of dermal collagen in photoaged skin using low‐dose 5‐aminolevulinic acid photodynamic therapy occurs via the transforming growth factor‐β pathway

Peiru Wang, Minglei Wei, Yuting Xu, Guolong Zhang, Haiyan Zhang, Lei Shi, Xiaojing Liu, Michael R Hamblin, Xiuli Wang

Article1997

Hormonal modulation of the accumulation of 5‐aminolevulinic acid‐induced protoporphyrin and phototoxicity in prostate cancer cells

Tetsuo Momma, Michael R Hamblin, Tayyaba Hasan